MARKET

BLRX

BLRX

Biolinerx
NASDAQ
0.2334
+0.0106
+4.76%
Pre Market: 0.2226 -0.0108 -4.63% 04:30 12/26 EST
OPEN
0.2220
PREV CLOSE
0.2228
HIGH
0.2342
LOW
0.2220
VOLUME
82
TURNOVER
63.75K
52 WEEK HIGH
1.640
52 WEEK LOW
0.1870
MARKET CAP
19.63M
P/E (TTM)
-0.8664
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BLRX last week (1216-1220)?
Weekly Report · 3d ago
Weekly Report: what happened at BLRX last week (1209-1213)?
Weekly Report · 12/16 10:22
Weekly Report: what happened at BLRX last week (1202-1206)?
Weekly Report · 12/09 10:20
Weekly Report: what happened at BLRX last week (1125-1129)?
Weekly Report · 12/02 10:20
JonesTrading Reaffirms Their Buy Rating on Bioline RX Ltd Sponsored ADR (BLRX)
TipRanks · 11/26 17:45
BioLineRx Reports Strategic Moves in Q3 2024
TipRanks · 11/26 03:55
BioLine RX Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 11/25 17:23
BioLine RX Price Target Cut to $9.00/Share From $21.00 by HC Wainwright & Co.
Dow Jones · 11/25 17:23
More
About BLRX
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.

Webull offers BioLine RX Ltd - ADR stock information, including NASDAQ: BLRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BLRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BLRX stock methods without spending real money on the virtual paper trading platform.